{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:08:27Z","timestamp":1791608907899,"version":"4.3.4"},"reference-count":19,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,5,3]]},"DOI":"10.3233\/jad-170091","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T18:25:12Z","timestamp":1490984712000},"page":"37-44","source":"Crossref","is-referenced-by-count":15,"title":["Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany"],"prefix":"10.1177","volume":"58","author":[{"given":"Jens","family":"Bohlken","sequence":"first","affiliation":[{"name":"Praxis f\u00fcr Neurologie und Psychiatrie, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Jacob","sequence":"additional","affiliation":[{"name":"Faculty of medicine, University of Paris 5, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[{"name":"Epidemiology, IMS Health, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-170091_ref3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1017\/S1041610215000654","article-title":"Continuous treatment with antidementia drugs in Germany 2003-2013: A retrospective database analysis","volume":"27","author":"Bohlken","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-170091_ref4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/11538230-000000000-00000","article-title":"Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study","volume":"27","author":"Kr\u00f6ger","year":"2010","journal-title":"Drugs Aging"},{"key":"10.3233\/JAD-170091_ref5","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00228-013-1483-y","article-title":"A population-based study of dosing and persistence with anti-dementia medications","volume":"69","author":"Brewer","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.3233\/JAD-170091_ref6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/11318010-000000000-00000","article-title":"Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer\u2019s disease: A 2-year prospective, multicentre, cohort study","volume":"24","author":"Gardette","year":"2010","journal-title":"CNS Drugs"},{"key":"10.3233\/JAD-170091_ref7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5414\/CP202631","article-title":"Persistence with antipsychotics in dementia patients in Germany","volume":"54","author":"Booker","year":"2016","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.3233\/JAD-170091_ref8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5414\/CP202572","article-title":"Persistence with antidepressant drugs in patients with dementia: A retrospective database analysis","volume":"54","author":"Booker","year":"2016","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.3233\/JAD-170091_ref9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/070674371405901203","article-title":"Persistence and adherence with dementia pharmacotherapy: Relevance of patient, provider, and system factors","volume":"59","author":"Maxwell","year":"2014","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"10.3233\/JAD-170091_ref10","first-page":"CD005593","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-170091_ref12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40263-013-0133-3","article-title":"A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer\u2019s disease in Europe: Predictors of discontinuation and switch in the ICTUS study","volume":"28","author":"Gardette","year":"2014","journal-title":"CNS Drugs"},{"key":"10.3233\/JAD-170091_ref13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5414\/CPP47617","article-title":"Validity and representativeness of the \u201cDisease Analyzer\u201d patient database for use in pharmacoepidemiological and pharmacoeconomic studies","volume":"47","author":"Becher","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"7","key":"10.3233\/JAD-170091_ref14","first-page":"1059","article-title":"Hip fracture risk in patients with dementia in German primary care practices","volume":"28","author":"Bohlken","year":"2015","journal-title":"Dementia (London)"},{"key":"10.3233\/JAD-170091_ref15","unstructured":"Bohlken J , Jacob L , Kostev K (2016) Progression of mild cognitive impairment to dementia in German specialist practices. Dementia (London), doi: 10.1177-1471301216673919"},{"key":"10.3233\/JAD-170091_ref16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S1041610215002082","article-title":"Risk factors for dementia diagnosis in German primary care practices","volume":"28","author":"Booker","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-170091_ref17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/gps.409","article-title":"Galantamine: A randomized, double-blind, dose comparison in patients with Alzheimer\u2019s disease","volume":"16","author":"Wilkinson","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-170091_ref18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00002512-200926030-00004","article-title":"Optimal dosing of galantamine in patients with mild or moderate Alzheimer\u2019s disease: Post Hoc analysis of a randomized, double-blind, placebo-controlled trial","volume":"26","author":"Aronson","year":"2009","journal-title":"Drugs Aging"},{"key":"10.3233\/JAD-170091_ref19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/gps.1133","article-title":"Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer\u2019s disease: A meta-analysis of individual patient data from randomised controlled trials","volume":"19","author":"Whitehead","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-170091_ref20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/cns.12158","article-title":"A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg\/24 h versus 4.6 mg\/24 h in severe Alzheimer\u2019s dementia","volume":"19","author":"Farlow","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.3233\/JAD-170091_ref21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","article-title":"Efficacy and safety of memantine in patients with mild to moderate vascular dementia","volume":"33","author":"Orgogozo","year":"2002","journal-title":"Stroke"},{"key":"10.3233\/JAD-170091_ref22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/alzrt160","article-title":"Memantine in patients with Alzheimer\u2019s disease receiving donepezil: New analyses of efficacy and safety for combination therapy","volume":"5","author":"Atri","year":"2013","journal-title":"Alzheimers Res Ther"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-170091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:42Z","timestamp":1777370622000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-170091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":19,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-170091","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]}}}